NCT05288062 · OUTCOME

Predictive Biomarkers

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma · Source last updated 2025-08-20

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Up to 6 months

What was measured

Biomarkers and RR will be analyzed using logistic regressions to identify predictive biomarkers.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Biomarkers and RR will be analyzed using logistic regressions to identify predictive biomarkers.
reporting Status: NOT_POSTED
time Frame: Up to 6 months
title: Predictive Biomarkers
type: SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice